The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer

被引:0
作者
J. S. Thomas
A. M. Hanby
N. Russell
G. van Tienhoven
K. Riddle
N. Anderson
D. A. Cameron
J. M. S. Bartlett
T. Piper
C. Cunningham
P. Canney
I. H. Kunkler
机构
[1] Western General Hospital,Department of Pathology
[2] St James’s University Hospital,Leeds Institute of Cancer and Pathology
[3] Netherlands Cancer Institute,Department of Radiation Oncology
[4] University of Amsterdam,Academic Medical Center
[5] NHS National Services Scotland,Scottish Clinical Trials Research Unit
[6] Edinburgh University Medical School,Centre of Population Health Sciences
[7] Western General Hospital,Edinburgh Cancer Centre
[8] Ontario Institute for Cancer Research,undefined
[9] Beatson Oncology Centre,undefined
来源
Breast Cancer Research and Treatment | 2017年 / 163卷
关键词
Breast cancer; Radiation therapy; Clinical trial; Pathology; Quality assurance;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:63 / 69
页数:6
相关论文
共 47 条
[1]  
Elston CW(1991)Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 403-410
[2]  
Ellis IO(1982)A prognostic index in primary breast cancer Br J Cancer 45 361-366
[3]  
Haybittle JL(2015)Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer (ARTemis): an open-label randomised phase 3 trial Lancet Oncol 16 656-666
[4]  
Blamey RW(2012)The prognostic significance of lymphovascular invasion in invasive breast carcinoma Cancer 118 3670-3680
[5]  
Elston C(1998)Obvious peritumoural emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers Eur J Cancer 34 58-65
[6]  
Earl HE(2006)Prognostic value of lymphovascular invasion in women with lymph node negative breast carcinoma Eur J Cancer 42 357-362
[7]  
Hiller L(1999)10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomised trial J Clin Oncol 17 2326-2333
[8]  
Dunn JA(2015)Addressing overtreatment of screen detected DCIS; the LORIS trial Eur J Cancer 51 2296-2303
[9]  
Rakha EA(2015)Diagnostic concordance among pathologists interpreting breast biopsy specimens JAMA 313 1122-1132
[10]  
Martin S(2017)Review of the national external quality assessment (EQA) scheme for breast pathology in the UK J Clin Pathol 70 51-57